Parkinsonism after Taking Ecstasy
New England Journal of Medicine – May 06, 1999
Source: OpenAlex
Summary
Repeated use of MDMA, commonly known as ecstasy, can lead to unexpected health issues, including parkinsonism. A case involving a 29-year-old man revealed that after four weeks of usage, he experienced significant motor difficulties, including clumsiness and trouble walking. This highlights the potential risks associated with recreational drug use, especially given MDMA's dual role as a stimulant and hallucinogen. As its popularity grows in Europe and the U.S., understanding the pharmacological effects on neurotransmitter systems like dopamine becomes crucial for both medicine and forensic toxicology.
Abstract
To the Editor: Recreational use of 3,4-methylenedioxymethamphetamine (MDMA, or “ecstasy”), a hallucinogen, has increased both in Europe and the United States.1 This substance is manufactured in illicit laboratories from a variety of organic ketone precursors. MDMA, which is structurally related both to the stimulant amphetamine and to the hallucinogen mescaline, promotes the release of both serotonin and dopamine from synaptic terminals.2 We report a case of parkinsonism after repeated use of this drug. A 29-year-old man had slight clumsiness of his upper and lower extremities in August 1998. During the following four weeks he began to have difficulty walking and . . .